- Location
Prometheus
"-
Prometheus Is Set to Begin Phase IV Multi-Center Study of Proleukin
Jun 4, 2013Speciality pharmaceutical and diagnostic company, Prometheus is set to begin Proclivity02, a study that compares the sequence of Proleukin (High Dose Interleukin-2 (HD IL-2) therapy at multi centers in US for metastatic melanoma (mM). ...
-
Prometheus Laboratories Is Enrolling Patients for Proclivity 01
May 14, 2013Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
-
Hibiscus Will Demonstrate Its New Products at Chemspec Europe 2013
Apr 8, 2013Label and software company Hibiscus will demonstrate its new products at Chemspec Europe 2013, to be held from 5 to 6 June 2013 in Munich, Germany. New packages, which have been recently launched for both classification, called ...
-
Prometheus Launches Has Introduced New Prometheus Anser Infliximab (Ifx) Monitoring Test
Dec 18, 2012Prometheus Laboratories, a developer of diagnostic products, has introduced new Prometheus Anser infliximab (IFX) monitoring test. By utilizing the company's proprietary homogenous mobility shift assay (HMSA), the test measures infliximab ...
Tags: Prometheus, IFX, monitoring test, HMSA, IBD
-
Building Larger Plants Doesn't Make Sense in Thin-Film Solar
Dec 13, 2012When the Chinese energy giant Hanergy decided last week to buy Miasole,a Silicon Valley-based thin-film solar company,at less than a tenth the amount venture capitalists had invested in the firm,it could have been making a savvy move.Though ...
-
Pathwork Diagnostics Named Lee McCracken as The Company's New Chief Executive Officer
Dec 7, 2012Pathwork Diagnostics, a developer of oncology diagnostics assays, has named Lee McCracken as the company's new chief executive officer (CEO). Pathwork Diagnostics board chairman Peter Klemm said,"Lee, with his considerable leadership and ...
Tags: Pathwork Diagnostics, Lee McCracken, CEO
-
A Stake Has Been Perchased Medical Food Company Accera by Nestlé Health Science
Dec 4, 2012Nestlé Health Science has purchased an undisclosed stake in Accera, a privately-held US-based company that is involved in the development and the commercialization of medical foods for neurodegenerative disorders such as Alzheimer's ...
-
Prometheus Laboratories Has Granted an Oncology Programme to Clinipace Worldwide
Nov 29, 2012Pharmaceutical and diagnostic company Prometheus Laboratories has granted an oncology programme to Clinipace Worldwide, a global digital research organization (dCRO). As part of the contract, Clinipace Worldwide will study Proleukin ...
Tags: medical research, data management platform, clinical trial
-
Nestle's Share Price Increased This Morning as The Kit-Kat Maker Booked an Increase
Aug 13, 2012Nestle's share price increased this morning (9 August) as the Kit-Kat maker booked an increase in first-half profit and reaffirmed its full-year guidance. The Swiss food giant reported an 8.9% increase in earnings of CHF5.12bn (US$5.26bn) ...
Tags: food, share price, emerging markets, price rises, cost-cutting, water
-
The World Has Lost One of The Greatest Writer
Jun 7, 2012Ray Bradbury, beloved science fiction author, dies The world has lost one of the greatest writer. His legacy will inspire generations of fans. Ray Bradbury, one of the most celebrated among 20th century writers of science fiction and ...
Tags: Ray Bradbury, writer, legacy
